Huang, Lynn Y L <br/><br/>
Activity of a novel Hec1-targeted anticancer compound against breast cancer cell lines in vitro and in vivo.  [electronic resource] 

 -  Molecular cancer therapeutics  Jun 2014 
 - 1419-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-13-0700  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Apoptosis--genetics<br/>Breast Neoplasms--drug therapy<br/>Cytoskeletal Proteins<br/>Doxorubicin--administration & dosage<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Heterocyclic Compounds, 4 or More Rings<br/>Humans<br/>In Vitro Techniques<br/>MCF-7 Cells<br/>Mice<br/>Molecular Targeted Therapy<br/>Niacinamide--administration & dosage<br/>Nuclear Proteins--antagonists & inhibitors<br/>Thiazoles--administration & dosage<br/>Xenograft Model Antitumor Assays